Brief: Hls Therapeutics Reports Qtrly Loss Per Share $0.15
06/05/2021 11:43
May 6 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES FIRST QUARTER FISCAL 2021
FINANCIAL
RESULTS
* HLS THERAPEUTICS INC - QTRLY Q1 2021 REVENUE OF $14.3
MILLION
* HLS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nCNWXXCNHa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group